| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | INTRA CELLULAR THERAPIES INC COM | 294,000 | 8,173,000 | 0.09% | ||
| 102 | ULTRAGENYX PHARMACEUTICAL INC COM | 128,300 | 8,123,000 | 0.09% | ||
| 103 | ENANTA PHARMACEUTICALS INC COM | 249,400 | 7,325,000 | 0.08% | ||
| 104 | Biotie Therapies Corp. | 268,672 | 7,090,000 | 0.07% | ||
| 105 | ASSEMBLY BIOSCIENCES INC | 1,397,100 | 7,013,000 | 0.07% | ||
| 106 | Redhill Biopharma Ltd | 564,900 | 6,920,000 | 0.07% | ||
| 107 | INCYTE CORP | 4,250,000 | 6,727,000 | 0.07% | PRN | |
| 108 | INCYTE CORP | 4,250,000 | 6,574,000 | 0.07% | PRN | |
| 109 | SYNERGY PHARMACEUTICALS DEL COM NEW | 2,276,648 | 6,284,000 | 0.07% | ||
| 110 | MACROGENICS INC | 317,000 | 5,944,000 | 0.06% | ||
| 111 | ADVAXIS INC COM NEW | 636,600 | 5,748,000 | 0.06% | ||
| 112 | QIAGEN NV | 256,800 | 5,737,000 | 0.06% | ||
| 113 | FLUIDIGM CORP DEL | 10,000,000 | 5,553,000 | 0.06% | PRN | |
| 114 | Lion Biotechnologies | 1,022,100 | 5,192,000 | 0.05% | ||
| 115 | MARINUS PHARMACEUTICALS INC | 965,000 | 5,192,000 | 0.05% | ||
| 116 | VALEANT PHARMACEUTICALS INTL | 194,900 | 5,126,000 | 0.05% | ||
| 117 | INVITAE CORP | 456,666 | 4,672,000 | 0.05% | ||
| 118 | CONNECTURE INC COM | 1,740,000 | 4,454,000 | 0.05% | ||
| 119 | SERES THERAPEUTICS INC | 166,645 | 4,426,000 | 0.05% | ||
| 120 | MIRATI THERAPEUTICS INC COM | 197,859 | 4,234,000 | 0.04% | ||
| 121 | Ascendis Pharma | 222,223 | 4,122,000 | 0.04% | ||
| 122 | ADAPTIMMUNE THERAPEUTICS PLC | 438,784 | 3,567,000 | 0.04% | ||
| 123 | CERUS CORP | 578,300 | 3,429,000 | 0.04% | ||
| 124 | MYLAN N V | 69,800 | 3,235,000 | 0.03% | ||
| 125 | Anacor Pharmaceuticals Inc | 53,300 | 2,849,000 | 0.03% | ||
| 126 | ALIMERA SCIENCES INC | 1,500,000 | 2,625,000 | 0.03% | ||
| 127 | ROKA BIOSCIENCE INC | 3,220,429 | 2,222,000 | 0.02% | ||
| 128 | UNIQURE NV | 184,800 | 2,195,000 | 0.02% | ||
| 129 | OREXIGEN THERAPEUTICS INC | 5,210,000 | 2,149,000 | 0.02% | PRN | |
| 130 | PORTOLA PHARMACEUTICALS INC | 100,000 | 2,040,000 | 0.02% | Put | |
| 131 | MEDIGUS LTD | 600,000 | 1,608,000 | 0.02% | ||
| 132 | ACHILLION PHARMACEUTICALS INC COM | 200,000 | 1,544,000 | 0.02% | Call | |
| 133 | XTANT MED HLDGS INC | 475,439 | 1,288,000 | 0.01% | ||
| 134 | FATE THERAPEUTICS INC COM | 692,900 | 1,247,000 | 0.01% | ||
| 135 | PERNIX THERAPEUTICS HLDGS IN | 1,073,000 | 1,127,000 | 0.01% | ||
| 136 | Cogentix Medical Inc | 990,745 | 1,090,000 | 0.01% | ||
| 137 | BIOLINERX LTD | 1,038,600 | 1,059,000 | 0.01% | ||
| 138 | QLT INC | 500,000 | 995,000 | 0.01% | ||
| 139 | BioMarin Pharmaceutical Inc | 500,000 | 594,000 | 0.01% | PRN | |
| 140 | BIOMARIN PHARMACEUTICAL INC | 500,000 | 579,000 | 0.01% | PRN | |
| 141 | AMARIN CORP PLC | 350,000 | 536,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003439, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
